Pulished : October, 2018
ID: 21
Region: Global
Share on

According to Market Data Forecast’s recent report, the Global Antifungal Drugs Market is predicted to reach $14.56 USD billion by 2021 with a CAGR of 3.68%.

Pulished: October, 2018
ID: 21
Share on

The Antifungal Drugs Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Antifungal Drugs Market is estimated to be $12.15 USD billion in 2016 and predicted to rise to $14.56 USD billion by 2021 with a CAGR of 3.68%. The market is segmented by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs), by type of Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other therapeutic indications) and by Application (Powders, Ointments, Drugs, Pastes). Geographically the Antifungal Drugs Market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.

Growing awareness of fungal infections and antifungal drugs is the major driver for the dental consumables market according to analysts at Market Data Forecast. And also the report stated that increasing incidence of fungal infections, rise in government and corporate funds for the industry and increasing healthcare expenditure in emerging countries are also driving the market growth. Rising popularity and demand for over-the-counter antifungal drugs for dermal infections is responsible for the growth of the market.

According to Market Data Forecast report, Azoles antifungal drugs market is the largest segment of the market because of the growing awareness of the Azoles drugs. Allylamines antifungal drugs market is the fastest growing segment of the market. Use of conventional drugs for infections is restraining the market growth. Cost of the drugs and their effectiveness in treatments are the key challenges for the market.

North America is leading the market according to the report, with United States commanding the major share because of the presence of major market players in the region. In emerging markets like china and India, the consumer base is growing rapidly because of growing awareness of fungal infections leading to the fastest growth of the market.

The report includes analysis of market leaders like Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/” and checkout our recent reports in the Pharmaceuticals category at “http://www.marketdataforecast.com/research-reports/healthcare/pharmaceuticals-1/”. For more insights and up-to-date industry news, don’t forget subscribing to our newsletters.